CTOs on the Move

SafeGraph

www.safegraph.com

 
SafeGraph graphs datasets together to solve humanity`s biggest secrets.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

SafeGraph raised $16M on 04/19/2017
SafeGraph raised $45M on 03/16/2021

Similar Companies

Microsoft Office

Collaborate for free with online versions of Microsoft Word, PowerPoint, Excel, and OneNote. Save documents, spreadsheets, and presentations online, in OneDrive. Share them with others and work together at the same time.

boberdoo.com

boberdoo.com | Lead Distribution Software, Ping/Post & Call Routing. boberdoo.com is a SaaS solution for the lead generation industry.

Shardeum

Shardeum is an EVM-based, linearly scalable network that provides low gas fees forever while maintaining true decentralization and solid security

Merrco Payments

Merrco`s payment gateway technology provides a fully customizable method to regulate a direct‑to-consumer cannabis mail‑order system in Canada. This system ensures cannabis can only be sold to Canadians legally allowed to purchase, while eliminating any entry point for illicit‑market activity.

Kapost

Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.